During a live event, Catherine J. Lee, MD, MS, discussed the mechanism of action of approved therapies for chronic ...

As the life sciences, medtech, and diagnostic industries continue to expand and grow increasingly complex, so does the legal, regulatory, ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced the launch ...

This came as part of the continuous regulatory surveillance, where drug samples are picked from sales/distribution points, ...

The investigational aldosterone synthase inhibitor lorundrostat effectively lowered 24-hour BP for adults with well-treated, ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Thirty-eight drug samples, including 10 injections, manufactured by various pharmaceutical companies in the state, have ...

Some blood pressure medications are not the best choice anymore, either due to their side effects or limited effectiveness.

Some drugs are known as nephrotoxic, which means that their effects can cause damage to the kidneys. Drugs such as certain ...

Stock futures inched up on Thursday as investors assessed President Donald Trump’s 25% tariff on foreign cars, which is set ...

The global telmisartan market was valued at $3,453 million in 2019, and is projected to reach $4,258 million by 2027, registering a CAGR of 3.4% from 2020 to 2027. The growth of the global telmisartan ...